Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/22/2850867/0/en/NMD-Pharma-Receives-FDA-IND-Clearance-to-initiate-a-Phase-2b-Clinical-Trial-of-NMD670-in-Generalized-Myasthenia-Gravis-Patients-in-the-US.html
https://www.globenewswire.com/news-release/2024/03/21/2850105/0/en/NMD-Pharma-Publishes-Comprehensive-Data-Package-for-NMD670-in-Science-Translational-Medicine.html
https://www.globenewswire.com//news-release/2024/03/01/2839037/0/en/NMD-Pharma-announces-poster-and-oral-presentations-on-skeletal-muscle-targeted-ClC-1-therapy-at-two-leading-neuromuscular-disease-conferences.html
https://www.globenewswire.com//news-release/2024/01/22/2812912/0/en/NMD-Pharma-Appoints-Morten-Bull-as-SVP-General-Counsel-and-Head-of-People-Business-Services.html
https://www.globenewswire.com//news-release/2023/11/15/2780883/0/en/NMD-Pharma-Raises-75-Million-80-million-in-a-Series-B-Financing.html
https://www.globenewswire.com//news-release/2023/10/03/2753439/0/en/NMD-Pharma-to-present-NMD670-clinical-data-from-a-Phase-I-IIa-trial-in-myasthenia-gravis-at-the-28th-International-Annual-Congress-of-the-World-Muscle-Society.html
https://www.globenewswire.com//news-release/2023/10/03/2753269/0/en/NMD-Pharma-to-present-NMD670-clinical-data-from-a-Phase-I-IIa-trial-in-myasthenia-gravis-at-the-28th-International-Annual-Congress-of-the-World-Muscle-Society.html
https://www.globenewswire.com//news-release/2023/09/26/2749328/0/en/NMD-Pharma-initiates-Phase-II-trial-of-NMD670-in-Spinal-Muscular-Atrophy.html
https://www.globenewswire.com//news-release/2023/09/08/2739992/0/en/NMD-Pharma-to-host-a-Satellite-Symposium-and-present-new-clinical-data-at-the-148th-Annual-Meeting-of-the-American-Neurological-Association.html
https://www.globenewswire.com/news-release/2023/06/20/2690700/0/en/NMD-Pharma-Reports-Results-from-the-ESTABLISH-Study-an-International-Observational-Study-of-Neuromuscular-Function-in-Charcot-Marie-Tooth-Type-1-and-2.html